Charles Schwab’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-347,966
Closed -$12.4M 3104
2014
Q4
$12.4M Buy
347,966
+1,894
+0.5% +$56.5K 0.02% 750
2014
Q3
$9M Buy
346,072
+48,606
+16% +$1.4M 0.01% 907
2014
Q2
$9.83M Sell
297,466
-65,212
-18% -$1.88M 0.02% 857
2014
Q1
$10.9M Buy
362,678
+112,328
+45% +$3.87M 0.02% 742
2013
Q4
$7.6M Buy
250,350
+11,920
+5% +$328K 0.01% 930
2013
Q3
$7.99M Buy
238,430
+13,667
+6% +$314K 0.02% 783
2013
Q2
$3.58M Buy
+224,763
New +$3.11M 0.01% 1328

Other funds holding NPSP

Charles Schwab's NPSP Position: Q1 2015 in Review

Charles Schwab sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 347,966 shares — an estimated $12.4M sold.

Charles Schwab first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $12.4M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • Charles Schwab reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Charles Schwab sold 347,966 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $12.4M.
  • Charles Schwab first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Charles Schwab's NPS PHARMACEUTICALS INC position peaked at $12.4M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Charles Schwab's 13F filing for Q1 2015, filed 14 May 2015.